You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinoma endometrii

Showing 26 - 50 of 7,589
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hürthle Cell Carcinoma and Follicular Thyroid Carcinoma

Completed
  • Huerthle Cell Carcinoma
    • (no location specified)
    Jul 20, 2023

    Nasopharyngeal Carcinoma Trial in Hangzhou (Endostar and Envafolimab)

    Recruiting
    • Nasopharyngeal Carcinoma
    • Endostar and Envafolimab
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Sep 24, 2023

    Advanced Nasopharyngeal Carcinoma Trial in Hangzhou (SBRT)

    Recruiting
    • Advanced Nasopharyngeal Carcinoma
    • SBRT
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Dec 5, 2022

    Thyroid Cancer Trial (20 mg Famitinib & 1200 mg Adebrelimab)

    Not yet recruiting
    • Thyroid Cancer
    • 20 mg Famitinib & 1200 mg Adebrelimab
    • (no location specified)
    Nov 26, 2023

    Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Not yet recruiting
    • Clear Cell Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 18, 2023

    Metastatic Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Not yet recruiting
    • Metastatic Clear Cell Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 18, 2023

    Advanced Hepatocellular Carcinoma Trial in Zhuhai (GDKM-100 injection)

    Withdrawn
    • Advanced Hepatocellular Carcinoma
    • GDKM-100 injection
    • Zhuhai, Guangdong, China
      Zhuhai People'S Hospital
    Jan 16, 2023

    Hepatocellular Carcinoma Trial in United States (AZD5851)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • AZD5851
    • Duarte, California
    • +9 more
    Oct 12, 2023

    Epithelial Ovarian Carcinoma Stage III, Epithelial Ovarian Carcinoma Stage IV, Fallopian Tube Carcinoma Stage III Trial in China

    Recruiting
    • Epithelial Ovarian Carcinoma Stage III
    • +5 more
    • nab-paclitaxel combined with carboplatin
    • Guangzhou, Guangdong, China
    • +10 more
    Feb 19, 2023

    EsophaCap for the Detection of Early Esophageal Carcinoma

    Recruiting
    • Barrett Esophagus
    • +2 more
      • Baltimore, Maryland
      • +1 more
      Dec 8, 2022

      Endoscopic Submucosal Dissection Versus Esophagectomy for Early

      Completed
      • Esophageal Cancer
      • Endoscopic submucosal dissection
      • Esophagectomy
      • Shanghai, China
        Changhai Hospital, Naval Medical University
      Sep 27, 2023

      Ovarian Cancer Trial in France (tests to determine HRD status)

      Not yet recruiting
      • Ovarian Cancer
      • tests to determine HRD status
      • Amiens, France
      • +3 more
      Nov 22, 2023

      Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Toripalimab)

      Not yet recruiting
      • Locally Advanced Head and Neck Squamous Cell Carcinoma
      • (no location specified)
      Mar 20, 2023

      Hepatocellular Carcinoma Trial in Beijing (Sintilimab, Lenvatinib, radiotherapy)

      Recruiting
      • Hepatocellular Carcinoma
      • Beijing, Beijing, China
        Beijing Tsinghua Changgung Hospital
      Jan 5, 2023

      Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable Trial in Guangzhou (Cetuximab, Zimberelimab, Docetaxel)

      Not yet recruiting
      • Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable
      • Guangzhou, Guangdong, China
        Sun Yat-sen University
      Oct 24, 2023

      Advanced Biliary Tract Cancer, Neuroendocrine Tumors, Female Reproductive System Tumor Trial in Australia (Ipilimumab,

      Recruiting
      • Advanced Biliary Tract Cancer
      • +3 more
      • Albury, New South Wales, Australia
      • +11 more
      Oct 31, 2022

      Ovarian Clear Cell Carcinoma Trial in Houston (Dostarlimab, LB-100)

      Not yet recruiting
      • Ovarian Clear Cell Carcinoma
      • Houston, Texas
        M D Anderson Cancer Center
      Sep 26, 2023

      Head and Neck Squamous Cell Carcinoma, Locally Advanced Operable Trial in Guangzhou (Cadonilimab, Docetaxel, Cisplatin)

      Recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Locally Advanced Operable
      • Guangzhou, Guangdong, China
      • +1 more
      Sep 4, 2023

      Head and Neck Squamous Cell Carcinoma, PET/CT Trial (Neck dissection)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • PET/CT
      • Neck dissection
      • (no location specified)
      Jan 31, 2023

      Adrenocortical Carcinoma Trial in Ann Arbor (68Ga-R8760 injection at pre-defined dose levels, 68GA-R8760 injection)

      Recruiting
      • Adrenocortical Carcinoma
      • 68Ga-R8760 injection at pre-defined dose levels
      • 68GA-R8760 injection
      • Ann Arbor, Michigan
        University of Michigan Nuclear Medicine
      Aug 11, 2023

      Nasopharyngeal Carcinoma Trial in Hangzhou (Toripalimab)

      Recruiting
      • Nasopharyngeal Carcinoma
      • Hangzhou, Zhejiang, China
        Zhejiang Cancer Hospital
      Apr 2, 2023

      Hepatocellular Carcinoma Trial in Guangzhou (TACE-HACI, plus atezolizumab-bevacizumab)

      Recruiting
      • Hepatocellular Carcinoma
      • TACE-HACI, plus atezolizumab-bevacizumab
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Feb 20, 2023

      Unresectable Hepatocellular Carcinoma Trial in Nanjing (Yttrium-90 carbon microspheres SIRT)

      Recruiting
      • Unresectable Hepatocellular Carcinoma
      • Yttrium-90 carbon microspheres SIRT
      • Nanjing, China
        Gao-Jun Teng
      Jul 20, 2023

      Biliary Carcinoma Trial in China (TQB3454 tablets, TQB3454 tablets matching )

      Not yet recruiting
      • Biliary Carcinoma
      • TQB3454 tablets
      • TQB3454 tablets matching placebo
      • Beijing, Beijing, China
      • +5 more
      Aug 4, 2023

      Keratinocyte Skin Cancer Trial in Wuppertal (Nevisense)

      Recruiting
      • Keratinocyte Skin Cancer
      • Nevisense
      • Wuppertal, Germany
        CentroDerm
      Sep 28, 2023